Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicOTC:GNBP
Raised
Post IPO Valuation
Acquired byLion Biotechnologies
Date10/2013

General Information

Websitegenesis-biopharma...
CategoryBioTech
Phone866-963-2220
Employees

Offices

Los Angeles, USA
10960 Wilshire Boulevard
Suite 1050
Los Angeles, CA, 90024
USA

People

Director
CFO & Director

Funding

TOTAL $2.74M
FUNDING TOTAL $2.74M
Venture Round, 9/2010
$500k
Venture Round, 11/2010
$250k
Venture Round, 1/2011
$640k
Venture Round, 6/2013
$1.35M
DEBT TOTAL $5M
Debt, 8/2011
$5M

Tags

Genesis Biopharma

Genesis Biopharma, Inc. Merge with Lion Biotechnologies, Inc.

Genesis Biopharma, Inc. (OTCBB: GNBP) is developing autologous cell therapies for the treatment of cancer.

Our lead product candidate, Cōntego™, is an autologous cell therapy using tumor infiltrating lymphocytes (TILs) indicated for the treatment of metastatic melanoma. Cōntego™ is being developed as a ready-to-infuse autologous cell therapy product. Following resection of the patient’s tumor, TILs are isolated from the resected tumor, and expanded in vitro to several billion cells. The expanded TILs are then infused into the patient where they attack the melanoma tumors regardless of their location in the body.

Cōntego™ is based on the adoptive cell therapy regimen using tumor infiltrating lymphocytes invented by Dr. Steven A. Rosenberg, Chief, Surgery Branch, Center for Cancer Research, National Cancer Institute for the treatment of metastatic melanoma. Dr. Rosenberg’s adoptive cell therapy is presently available as a physician-sponsored investigational therapy for the treatment of Stage IV metastatic melanoma at the National Cancer Institute, MD Anderson Cancer Center, and the H. Lee Moffitt Cancer & Research Institute.

Recent Milestones

Videos

Screenshots

Stock Price

Sources

  1. Genesis Biopharma Announces Completion of Merger with Lion Biotechnologies (finance.yahoo.com) [edit]
  2. SEC (sec.gov) [edit]
  3. SEC (sec.gov) [edit]
  4. SEC (sec.gov) [edit]
  5. SEC (sec.gov) [edit]
  6. SEC (sec.gov) [edit]
  7. Genesis Biopharma Announces Completion of Merger with Lion Biotechnologies (finance.yahoo.com) [edit]
Edit This Page
Last Edited 1/31/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy